• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级护理教学医院医护人员对药物警戒的认知、态度及实践

Knowledge, Attitude, and Practice of Materiovigilance Among Healthcare Professionals at a Tertiary Care Teaching Hospital.

作者信息

Sojitra Brijesh, Patel Chetna, Pandya Sajal, Virani Payal, Shah Paras, Patel Jaykumar, Shah Akash

机构信息

Pharmacology, Government Medical College, Surat, Surat, IND.

Pharmacology, Pandit Dindayal Upadhyay Medical College, Rajkot, IND.

出版信息

Cureus. 2024 Jul 20;16(7):e64978. doi: 10.7759/cureus.64978. eCollection 2024 Jul.

DOI:10.7759/cureus.64978
PMID:39161496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11332695/
Abstract

Objective This study aimed to assess the knowledge, attitudes, and practices (KAP) of materiovigilance among healthcare professionals (HCPs) at a tertiary care teaching hospital in South Gujarat, India. Specifically, it sought to identify gaps in current understanding and reporting practices related to adverse events associated with medical devices. Introduction Materiovigilance, the systematic monitoring and assessment of adverse events related to medical devices, is crucial for ensuring patient safety and enhancing device performance. In India, the Materiovigilance Programme of India (MvPI) under the Ministry of Health and Family Welfare oversees the safe use of medical devices, integrating them with the pharmacovigilance framework. Despite these efforts, challenges persist in awareness, reporting practices, and the integration of materiovigilance among healthcare professionals. The knowledge, attitude, and practice (KAP) of these professionals are pivotal for effective adverse event reporting, but underreporting due to a lack of awareness, inadequate training, and perceived administrative burden remains a significant barrier. The study underscores the importance of training programs, improving reporting infrastructure, and fostering a safety culture within healthcare institutions to enhance the effectiveness of materiovigilance in India. Methodology An observational, cross-sectional study was conducted using a questionnaire-based approach. A total of 215 HCPs, including consultant doctors, resident doctors, and nursing staff, participated in the study. The questionnaire covered aspects of knowledge regarding the Materiovigilance Programme of India (MvPI), classification of medical devices, attitudes towards adverse event reporting, and actual reporting practices. Data collection was carried out electronically over the course of one month using Google Forms (Google LLC, Mountain View, California, United States). Results Among the participants, 135 (62.79%) correctly identified MvPI as the program for monitoring adverse events caused by medical devices. A majority of 188 (87.44%) understood that medical devices in India are classified based on a risk-based approach. Positive attitudes towards reporting adverse events were prevalent, with 202 (93.95%) acknowledging the potential for adverse events from medical devices and agreeing on the importance of reporting. However, a significant gap was noted between noticing adverse events (138 participants, 64.19%) and actual reporting (60 participants, 27.91%), indicating a need for improved reporting practices. Only 104 participants (48.37%) had participated in workshops or continuing medical education (CME) sessions on medical device safety. Conclusion The study reveals a strong foundation of knowledge and positive attitudes towards the materiovigilance among HCPs in South Gujarat. However, there is a notable discrepancy between awareness and actual reporting practices. To enhance the effectiveness of materiovigilance, interventions such as targeted educational programs and simplification of reporting procedures are recommended. These efforts are essential to ensure timely detection, reporting, and management of adverse events related to medical devices, thereby enhancing patient safety and overall healthcare quality.

摘要

目的 本研究旨在评估印度古吉拉特邦南部一家三级护理教学医院的医护人员对医疗器械警戒的知识、态度和实践(KAP)。具体而言,它试图找出当前在与医疗器械相关不良事件的理解和报告实践方面的差距。

介绍 医疗器械警戒是对与医疗器械相关不良事件的系统监测和评估,对于确保患者安全和提高器械性能至关重要。在印度,卫生与家庭福利部下属的印度医疗器械警戒计划(MvPI)负责监督医疗器械的安全使用,并将其与药物警戒框架相结合。尽管做出了这些努力,但在医护人员的认知、报告实践以及医疗器械警戒的整合方面仍存在挑战。这些专业人员的知识、态度和实践对于有效的不良事件报告至关重要,但由于缺乏认知、培训不足以及感知到的行政负担导致的报告不足仍然是一个重大障碍。该研究强调了培训计划、改善报告基础设施以及在医疗机构中培育安全文化对于提高印度医疗器械警戒有效性的重要性。

方法 采用基于问卷的方法进行了一项观察性横断面研究。共有215名医护人员参与了研究,包括顾问医生、住院医生和护理人员。问卷涵盖了关于印度医疗器械警戒计划(MvPI)的知识、医疗器械分类、对不良事件报告的态度以及实际报告实践等方面。数据收集在一个月的时间内通过谷歌表单(谷歌有限责任公司,美国加利福尼亚州山景城)以电子方式进行。

结果 在参与者中,135人(62.79%)正确将MvPI识别为监测医疗器械引起不良事件的计划。大多数188人(87.44%)了解印度的医疗器械是基于风险的方法进行分类的。对报告不良事件持积极态度很普遍,202人(93.95%)承认医疗器械存在不良事件的可能性,并认同报告的重要性。然而,在注意到不良事件(138名参与者,64.19%)和实际报告(60名参与者,27.91%)之间存在显著差距,表明需要改进报告实践。只有104名参与者(48.37%)参加过关于医疗器械安全的研讨会或继续医学教育(CME)课程。

结论 该研究揭示了古吉拉特邦南部医护人员对医疗器械警戒有坚实的知识基础和积极态度。然而,在认知和实际报告实践之间存在明显差异。为了提高医疗器械警戒的有效性,建议采取有针对性的教育计划和简化报告程序等干预措施。这些努力对于确保及时发现、报告和管理与医疗器械相关的不良事件至关重要,并从而提高患者安全和整体医疗质量。

相似文献

1
Knowledge, Attitude, and Practice of Materiovigilance Among Healthcare Professionals at a Tertiary Care Teaching Hospital.三级护理教学医院医护人员对药物警戒的认知、态度及实践
Cureus. 2024 Jul 20;16(7):e64978. doi: 10.7759/cureus.64978. eCollection 2024 Jul.
2
Knowledge, Attitude, and Practice of Materiovigilance among Nurses at a Tertiary Care Hospital in South India: A Cross-Sectional Study.印度南部一家三级护理医院护士对药物警戒的知识、态度和实践:一项横断面研究。
J Pharm Bioallied Sci. 2022 Jul-Sep;14(3):162-167. doi: 10.4103/jpbs.jpbs_274_21. Epub 2022 Sep 19.
3
Study on the impact of sensitization on materiovigilance programme among pharmacy and dental postgraduate students.致敏作用对药学与牙科研究生药物警戒计划影响的研究。
Expert Rev Med Devices. 2024 Jun 6:1-10. doi: 10.1080/17434440.2024.2364821.
4
Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute of national importance: A cross-sectional study.一所具有国家重要性的三级医疗机构中医疗专业人员对药物警戒的认知、态度和实践:一项横断面研究。
Perspect Clin Res. 2022 Apr-Jun;13(2):94-98. doi: 10.4103/picr.PICR_187_19. Epub 2021 Jan 15.
5
A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India.印度南部一家教学医院医护人员药物警戒知识、态度及实践的问卷调查研究
Perspect Clin Res. 2015 Jan-Mar;6(1):45-52. doi: 10.4103/2229-3485.148816.
6
Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.评估医疗保健专业人员在药物警戒和药物不良反应报告方面的知识、态度、实践和障碍:一项跨中心的横断面研究。
PLoS One. 2023 May 24;18(5):e0285811. doi: 10.1371/journal.pone.0285811. eCollection 2023.
7
Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.探讨三级甲等医院医护人员参与药物警戒的影响因素和障碍:来自巴基斯坦开伯尔-普赫图赫瓦省的一项多中心研究。
Curr Med Res Opin. 2022 Apr;38(4):595-605. doi: 10.1080/03007995.2022.2042992. Epub 2022 Mar 3.
8
Materiovigilance Programme of India: A scheme to assure cardiovascular devices safety surveillance.印度药物警戒计划:保障心血管器械安全监测的方案。
Indian Heart J. 2020 Jul-Aug;72(4):316-318. doi: 10.1016/j.ihj.2020.06.009. Epub 2020 Jul 1.
9
Reporting of adverse events related to medical devices: A single-center experience from a tertiary care institute of national importance in India.医疗器械不良事件报告:印度一家具有国家重要性的三级保健机构的单中心经验。
Indian J Pharmacol. 2023 Mar-Apr;55(2):128-132. doi: 10.4103/ijp.ijp_495_21.
10
A cross sectional analysis of medical device associated adverse events with radiotherapy devices - A materiovigilance study.医疗器械相关不良事件与放射治疗设备的横断面分析-一项药物警戒研究。
Indian J Pharmacol. 2023 May-Jun;55(3):162-166. doi: 10.4103/ijp.ijp_818_22.

本文引用的文献

1
Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System.药物警戒透视:理解其在全球医疗保健系统中的概念与实践。
Ther Innov Regul Sci. 2023 Jul;57(4):886-898. doi: 10.1007/s43441-023-00514-4. Epub 2023 Apr 27.
2
Knowledge, Attitude, and Practice of Materiovigilance among Nurses at a Tertiary Care Hospital in South India: A Cross-Sectional Study.印度南部一家三级护理医院护士对药物警戒的知识、态度和实践:一项横断面研究。
J Pharm Bioallied Sci. 2022 Jul-Sep;14(3):162-167. doi: 10.4103/jpbs.jpbs_274_21. Epub 2022 Sep 19.
3
Materiovigilance Programme of India: Current status and way forward.
印度药物警戒计划:现状与未来方向。
Indian J Pharmacol. 2022 May-Jun;54(3):221-225. doi: 10.4103/ijp.ijp_837_21.
4
Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute of national importance: A cross-sectional study.一所具有国家重要性的三级医疗机构中医疗专业人员对药物警戒的认知、态度和实践:一项横断面研究。
Perspect Clin Res. 2022 Apr-Jun;13(2):94-98. doi: 10.4103/picr.PICR_187_19. Epub 2021 Jan 15.
5
A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations.全球药物警戒计划实施和效果的比较:法规概述。
Environ Sci Pollut Res Int. 2021 Nov;28(42):59608-59629. doi: 10.1007/s11356-021-16345-5. Epub 2021 Sep 13.
6
Materiovigilance: An Indian perspective.药物警戒:印度视角
Perspect Clin Res. 2018 Oct-Dec;9(4):175-178. doi: 10.4103/picr.PICR_26_18.
7
Pharmacovigilance in India: Present Scenario and Future Challenges.印度的药物警戒:现状与未来挑战。
Drug Saf. 2019 Mar;42(3):339-346. doi: 10.1007/s40264-018-0730-7.
8
Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.医疗保健专业人员对药物不良反应和药物警戒的认识与知识。
Saudi Med J. 2016 Dec;37(12):1359-1364. doi: 10.15537/smj.2016.12.17059.
9
A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India.在印度南部一家三级护理教学医院进行的一项基于问卷调查的研究,以评估本科医学生对药物警戒的知识、态度和实践。
Perspect Clin Res. 2015 Oct-Dec;6(4):217-21. doi: 10.4103/2229-3485.167102.
10
[Causes for the underreporting of adverse drug events by health professionals: a systematic review].[卫生专业人员对药物不良事件报告不足的原因:一项系统综述]
Rev Esc Enferm USP. 2014 Aug;48(4):739-47. doi: 10.1590/s0080-623420140000400023.